Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Kite Pharma
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Through this exclusive license agreement with Refuge’s platform, coupled with our unique in-house research capabilities, we aim to create a new generation of CAR T-cell products to induce long-term remissions for more patients.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 20, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Kite Pharma
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Reset All
